dermal fillers

Bacterial Biofilm and Soft-Tissue Fillers

Image of a syringe and ampoule

A study published in Plastic and Reconstructuve Surgery (March 2017) examined bacterial biofilm as a possible cause of adverse nodular reactions following treatment with filler injections. Researchers Mayuran Saththianathan, et al, performed an in vitro analysis of the propensity for three classes of filler materials to support biofilm growth; studied the effect of inoculation of filler material through a contaminated surface; and analyzed biopsy samples from patients presenting with chronic granulomatous inflammation following filler administration.

Allergan Launches Juvéderm Volite

Allergan has launched Juvéderm Volite, a hyaluronic-based injectable filler specifically designed to improve skin quality in the face, neck, décolletage and hands. Volite uses patented Vycross technology and is formulated to last up to nine months with a single treatment session. It should be injected intradermally and contains lidocaine for patient comfort.

Lovely Lips

The key to natural-looking lip augmentation lies in understanding facial anatomy and patient expectations.
Lovely Lips

Lip augmentation is one of the few aesthetic concerns that bridges all age groups. Young patients often come to practices seeking larger, more lustrous lips; while aging patients are dismayed at loss of definition and the appearance of perioral lines and wrinkles. In order to create the aesthetic outcomes these patients seek, one must gain an understanding of their desired outcomes and step back to examine the entire lower face.

Maximizing Safety During Facial Fillers

Maximizing Safety During Facial Fillers

In an article published in Plastic and Reconstructive Surgery (January 2017), Jack F. Scheuer III, MD, et al, outline general principles and safe practices for ensuring increased safety and better outcomes when administering facial filler injections. They posit that practitioners can tailor injection techniques to prevent vessel injury and avoid cannulation by considering the depth and the location of the vasculature within six “facial danger zones,” i.e., brows/glabella, temporal region, infraorbital area, lips/commissure, nasolabial folds and nose.

FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers

FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers

Galderma has received U.S. Food and Drug Administration (FDA) approval of two new Restylane products for the treatment of nasolabial folds (NLF) in patients over the age of 21. Restylane Refyne is approved for the treatment of moderate to severe facial wrinkles and folds, and Restylane Defyne for the treatment of moderate to severe, deep facial wrinkles and folds.

Restylane Turns 20

Galderma is celebrating 20 years of Restylane with new packaging and a new, more ergonomic syringe design.
Restylane Turns 20

Though silicone- and then collagen-based dermal fillers have been used since the 1940s to fill out facial defects, it was the introduction of hyaluronic acid (HA)-based dermal fillers that brought these treatments to the main­­stream. “HA fillers completely changed cosmetic medicine,” says facial plastic surgeon Steven Dayan, MD, clin­ical assistant professor at the University of Illinois. “They don’t just fill lines; they actually give volume back to the face. They also have a more natural feel than collagen and offer reversibility that is reliable.

Dermal Filler Treatments Continue to Gain in Popularity

Botulinum toxin injections remain the most popular noninvasive cosmetic procedure, but as they dipped slightly from 2014 to 2015, hyaluronic acid-based dermal filler treatments rose, according to the results of the newly released 2015 International Society of Aesthetic Plastic Surgery (ISAPS) Global Procedural Survey.
The three most popular surgical procedures worldwide include: